The use of n-3 polyunsaturated fatty acids as therapeutic agents for inflammatory diseases

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 9, Issue 1, 2009, Pages 45-54

  Calder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cytokine; Eicosanoid; Fatty acid; Fish oil; Inflammation

Indexed keywords

ARACHIDONIC ACID; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSANOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; ASTHMA; CHEMOTAXIS; CLINICAL TRIAL; CROHN DISEASE; CYTOKINE PRODUCTION; DIETARY INTAKE; DRUG EFFICACY; ENTERITIS; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; JOINT SWELLING; MORNING STIFFNESS; NONHUMAN; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 70350033469     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152209788009788     Document Type: Article

References (136)

1. Lewis, R.A.; Austen, K.F.; Soberman, R.J. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Eng. J. Med., 1990, 323, 645-655.
2. Tilley, S.L.; Coffman, T.M.; Koller, B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest., 2001, 108, 15-23.
3. Bagga, D.; Wang, L.; Farias-Eisner, R.; Glaspy, J.A.; Reddy, S.T. Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA, 2003, 100, 1751-1756.
4. Miles, E.A.; Allen, E.; Calder, P.C. In vitro effects of eicosanoids derived from different 20-carbon Fatty acids on production of monocyte-derived cytokines in human whole blood cultures. Cytokine, 2003, 20, 215-223.
5. Levy, B.D.; Clish, C.B.; Schmidt, B.; Gronert, K.; Serhan, C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol., 2001, 2, 612-619.
6. Vachier, I.; Chanez, P.; Bonnans, C.; Godard, P.; Bousquet, J.; Chavis, C. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem. Biophys. Res. Commun., 2002, 290, 219-224.
7. Serhan, C.N.; Jain, A.; Marleau, S.; Clish, C.; Kantarci, A.; Behbehani, B.; Colgan, S.P.; Stahl, G.L.; Merched, A.; Petasis, N.A.; Chan, L.; Van Dyke, T.E. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol., 2003, 171, 6856-6865.
8. Lee, T.H.; Hoover, R.L.; Williams, J.D.; Sperling, R.I.; Ravalese, J.; Spur, B.W.; Robinson, D.R.; Corey, E.J.; Lewis, R.A.; Austen, K.F. Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Eng. J. Med., 1985, 312, 1217-1224.
9. Endres, S.; Ghorbani, R.; Kelley, V.E.; Georgilis, K.; Lonnemann, G.; van der Meer, J.M.W.; Cannon, J.G.; Rogers, T.S.; Klempner, M.S.; Weber, P.C.; Schaeffer, E.J.; Wolff, S.M.; Dinarello, C.A. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Eng. J. Med., 1989, 320, 265-271.
10. Sperling, R.I.; Benincaso, A.I.; Knoell, C.T.; Larkin, J.K.; Austen, K.F.; Robinson, D.R. Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J. Clin. Invest., 1993, 91, 651-660.
11. Gibney, M.J.; Hunter, B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur. J. Clin. Nutr., 1993, 47, 255-259.
12. Caughey, G.E.; Mantzioris, E.; Gibson, R.A.; Cleland, L.G.; James, M.J. The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr., 1996, 63, 116-122.
13. Healy, D.A.; Wallace, F.A.; Miles, E.A.; Calder, P.C.; Newsholme, P. The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids, 2000, 35, 763-768.
14. Yaqoob, P.; Pala, H.S.; Cortina-Borja, M.; Newsholme, E.A.; Calder, P.C. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur. J. Clin. Invest., 2000, 30, 260-274.
15. Thies, F.; Nebe-von-Caron, G.; Powell, J.R.; Yaqoob, P.; Newsholme, E.A.; Calder, P.C. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J. Nutr., 2001, 131, 1918-1927.
16. Rees, D.; Miles, E.A.; Banerjee, T.; Wells, S.J.; Roynette, C.E.; Wahle, K.W.J.W.; Calder, P.C. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am. J. Clin. Nutr., 2006, 83, 331-342.
17. Meydani, S.N.; Endres, S.; Woods, M.M.; Goldin, B.R.; Soo, C.; Morrill-Labrode, A.; Dinarello, C.; Gorbach, S.L. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J. Nutr., 1991, 121, 547-555.
18. 2 production and T-cell function after fish-oil supplementation: response to antioxidant co-supplementation. Am. J. Clin. Nutr., 2003, 78, 376-382.
19. von Schacky, C.; Kiefl, R.; Jendraschak, E.; Kaminski, W.E. N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo and in vivo. J. Lab. Clin. Med., 1993, 121, 302-309.
20. 5) derived from eicosapentaenoic acid. Biochem. Biophys. Res. Commun., 1983, 117, 282-288.
21. Lee, T.H.; Mencia-Huerta, J.M.; Shih, C.; Corey, E.J.; Lewis, R.A.; Austen, K.F. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene-B5 and the double lipoxygenase product. J. Biol. Chem., 1984, 259, 2383-2389.
22. Serhan, C.N.; Clish, C.B.; Brannon, J.; Colgan, S.P.; Chiang, N.; Gronert, K. Novel functional sets of lipid-derived mediators with antinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med., 2000, 192, 1197-1204.
23. Serhan, C.N.; Clish, C.B.; Brannon, J.; Colgan, S.P.; Gronert, K.; Chiang, N. Anti-inflammatory lipid signals generated from dietary n-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and n-3 PUFA therapeutic actions. J. Physiol. Pharmacol., 2000, 4, 643-654.
24. Serhan, C.N.; Hong, S.; Gronert, K.; Colgan, S.P.; Devchand, P.R.; Mirick, G.; Moussignac, R-L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med., 2002, 196, 1025-1037.
25. Hong, S.; Gronert, K.; Devchand, P.; Moussignac, R.-L.; Serhan, C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autocoids in anti-inflammation. J. Biol. Chem., 2003, 278, 14677-14687.
26. Marcheselli, V.L.; Hong, S.; Lukiw, W.J.; Hua Tian, X.; Gronert, K.; Musto, A.; Hardy, M.; Gimenez, J.M.; Chiang, N.; Serhan, C.N.; Bazan, N.G. Novel docosanoids inhibit brain ischemia reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem., 2003, 278, 43807-43817.
27. Mukherjee, P.K.; Marcheselli, V.L.; Serhan, C.N.; Bazan, N.G. Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA, 2004, 101, 8491-8496.
28. Serhan, C.N.; Arita, M.; Hong, S.; Gotlinger, K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids, 2004, 39, 1125-1132.
29. Serhan, C.N. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotrectins. Curr. Opin. Clin. Nutr. Metab. Care, 2005, 8, 115-121.
30. Arita, M.; Yoshida, M.; Hong, S.; Tjonahen, E.; Glickman, J.N.; Petasis, N.A.; Blumberg, R.S.; Serhan, C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA, 2005, 102, 7671-7676.
31. Hudert, C.A.; Weylandt, K.H.; Lu, Y.; Wang, J.; Hong, S.; Dignass, A.; Serhan, C.N.; Kang, J.X. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA, 2006, 103, 11276-11281.
32. Schmidt, E.B.; Pedersen, J.O.; Ekelund, S.; Grunnet, N.; Jersild, C.; Dyerberg, J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis, 1989, 77, 53-57.
33. Schmidt, E.B.; Varming, K.; Pedersen, J.O.; Lervang, H.H.; Grunnet, N.; Jersild, C.; Dyerberg, J. Long term supplementation with n-3 fatty acids, ii: Effect on neutrophil and monocyte chemotaxis. Scand. J. Clin. Lab. Invest., 1992, 52, 229-236.
34. Luostarinen, R.; Siegbahn, A.; Saldeen, T. Effect of dietary fish oil supplemented with different doses of vitamin E on neutrophil chemotaxis in healthy volunteers. Nutr. Res., 1992, 12, 1419-1430.
35. Schmidt, E.B.; Pedersen, J.O.; Varming, K.; Ernst, E.; Jersild, C.; Grunnet, N.; Dyerberg, J. N-3 fatty acids and leukocyte chemotaxis: effects in hyperlipidemia, and dodse-response studies in healthy males. Arterioscler. Thromb., 1991, 11, 429-435.
36. Schmidt, E.B.; Varming, K.; Moller, J.M.; Bulow Pederson, I.; Madsen, P.; Dyerberg, J. No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand. J. Clin. Invest., 1996, 56, 87-92.
37. De Caterina, R.; Cybulsky, M.I.; Clinton, S.K.; Gimbrone, M.A.; Libby, P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb., 1994, 14, 1829-1836.
38. Collie-Duguid, E.S.; Wahle, K.W. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun., 1996, 220, 969-974.
39. Hughes, D.A.; Southon, S.; Pinder, A.C. (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J. Nutr., 1996, 126, 603-610.
40. Miles, E.A.; Wallace, F.A.; Calder, P.C. Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. Atherosclerosis, 2000, 152, 43-50.
41. Hughes, D.A.; Pinder, A.C.; Piper, Z.; Johnson, I.T.; Lund, E.K. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am. J. Clin. Nutr., 1996, 63, 267-272.
42. Miles, E.A.; Thies, F.; Wallace, F.A.; Powell, J.R.; Hirst, T.L.; Newsholme, E.A.; Calder, P.C. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci., 2001, 100, 91-100.
43. Khalfoun, B.; Thibault, F.; Watier, H.; Bardos, P.; Lebranchu, Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv. Exp. Biol. Med., 1997, 400, 589-597.
44. Babcock, T.A.; Novak, T.; Ong, E.; Jho, D.H.; Helton, W.S.; Espat, N.J. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J. Surg. Res., 2002, 107, 135-139.
45. Billiar, T.; Bankey, P.; Svingen, B.; Curran, R.D.; West, M.A.; Holman, R.T.; Simmons, R.L.; Cerra, F.B. Fatty acid uptake and Kupffer Cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery, 1988, 104, 343-349.
46. Renier, G.; Skamene, E.; de Sanctis, J.; Radzioch, D. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: modulation of macrophage secretory activities. Arterioscler. Thromb., 1993, 13, 1515-1524.
47. Yaqoob, P.; Calder, P.C. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol., 1995, 163, 120-128.
48. Gallai, V.; Sarchielli, P.; Trequattrini, A.; Franceschini, M.; Floridi, A.; Firenze, C.; Alberti, A.; Di Benedetto, D.; Stragliotto, E. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J. Neuroimmunol., 1993, 56, 143-153.
49. Abbate, R.; Gori, A.M.; Martini, F.; Brunelli, T.; Filippini, M.; Francalanci, I.; Paniccia, R.; Prisco, D.; Gensini, G.F.; Serneri, G.G.N. N-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prost. Leuk. Essent. Fatty Acids, 1996, 54, 439-444.
50. Kelley, D.S.; Taylor, P.C.; Nelson, G.J.; Schmidt, P.C.; Ferretti, A.; Erickson, K.L.; Yu, R.; Chandra, R.K. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids, 1999, 34, 317-324.
51. Mori, T.A.; Woodman, R.J.; Burke, V.; Puddey, I.B.; Croft, K.D.; Beilin, L.J. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Rad. Biol. Med., 2003, 35, 772-781.
52. Calder, P.C. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale? Nutr. Res., 2001, 21, 309-341.
53. Calder, P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr., 2006, 83, 1505S-1519S.
54. Cooper, A.L.; Gibbins, L.; Horan, M.A.; Little, R.A.; Rothwell, N.J. Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin. Nutr., 1993, 12, 321-328.
55. Thies, F.; Miles, E.A.; Nebe-von-Caron, G.; Powell, J.R.; Hurst, T.L.; Newsholme, E.A.; Calder, P.C. Influence of dietary supplementation with long chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids, 2001, 36, 1183-1193.
56. Kew, S.; Banerjee, T.; Minihane, A.M.; Finnegan, Y.E.; Muggli, R.; Albers, R.; Williams, C.M.; Calder, P.C. Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am. J. Clin. Nutr., 2003, 77, 1287-1295.
57. Wallace, F.A.; Miles, E.A.; Calder, P.C. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br. J. Nutr., 2003, 89, 679-689.
58. Leslie, C.A.; Gonnerman, W.A.; Ullman, M.D.; Hayes, K.C.; Franzblau, C.; Cathcart, E.S. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J. Exp. Med., 1985, 162, 1336-1349.
59. Volker, D.H.; FitzGerald, P.E.B.; Garg, M.L. The eicosapentaenoic to docosahexaenoic acid ratio of diets affects the pathogenesis of arthritis in Lew/SSN rats. J. Nutr., 2000, 130, 559-565.
60. Kremer, J.M.; Bigauoette, J.; Michalek, A.V.; Timchalk, M.A.; Lininger, L.; Rynes, R.I.; Huyck, C.; Zieminski, J.; Bartholomew, L.E. Effects of manipulation of dietary fatty acids on manifestations of rheumatoid arthritis. Lancet, 1985, 1(8422), 184-187.
61. Kremer, J.M.; Jubiz, W.; Michalek, A.; Rynes, R.I.; Bartholomew, L.E.; Bigouette, J.; Timchalk, M.; Beller, D.; Lininger, L. Fish-oil supplementation in active rheumatoid arthritis. Ann. Int. Med., 1987, 106, 497-503.
62. Cleland, L.G.; French, J.K.; Betts, W.H.; Murphy, G.A.; Elliot, M.J. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J. Rheumatol., 1988, 15, 1471-1475.
63. van der Tempel, H.; Tullekan, J.E.; Limburg, P.C.; Muskiet, F.A.J.; van Rijswijk, M.H. Effects of fish oil supplementation in rheumatoid arthritis. Ann. Rheum. Dis., 1990, 49, 76-80.
64. Tullekan, J.E.; Limburg, P.C.; Muskiet, F.A.J.; van Rijswijk, M.H. Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis. Arth. Rheum., 1990, 33, 1416-1419.
65. Kremer, J.M.; Lawrence, D.A.; Jubiz, W.; DiGiacomo, R.; Rynes, R.; Bartholomew, L.E.; Sherman, M. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arth. Rheum., 1990, 33, 810-820.
66. Esperson, G.T.; Grunnet, N.; Lervang, H.H.; Nielsen, G.L.; Thomsen, B.S.; Faarvang, K.L.; Dyerberg, J.; Ernst, E. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin. Rheumatol., 1992, 11, 393-395.
67. Sperling, R.I.; Weinblatt, M.; Robin, J.L.; Ravalese, J.; Hoover, R.L.; House, F.; Coblyn, J.S.; Fraser, P.A.; Spur, B.W.; Robinson, D.R. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arth. Rheum., 1987, 30, 988-997.
68. Kremer, J.M.; Lawrence, D.A.; Petrillo, G.F.; Litts, L.L.; Mullaly, P.M.; Rynes, R.I.; Stocker, R.P.; Parhami, N.; Greenstein, N.S.; Fuchs, B.R. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs: clinical and immune correlates. Arth. Rheum., 1995, 38, 1107-1114.
69. Skoldstam, L.; Borjesson, O.; Kjallman, A.; Seiving, B.; Akesson, B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis: a double blind, controlled study. Scand. J. Rheumatol., 1992, 21, 178-185.
70. Nielsen, G.L.; Faarvang, K.L.; Thomsen, B.S.; Teglbjaerg, K.L.; Jensen, L.T.; Hansen, T.M.; Lervang, H.H.; Schmidt, E.B.; Dyerberg, J.; Ernst, E. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur. J. Clin. Invest., 1992, 22, 687-691.
71. Kjeldsen-Kragh, J.; Lund, J.A.; Riise, T.; Finnanger, B.; Haaland, K.; Finstad, R.; Mikkelsen, K.; Forre, O. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J. Rheumatol., 1992, 19, 1531-1536.
72. Lau, C.S.; Morley, K.D.; Belch, J.J.F. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis. Br. J. Rheumatol., 1993, 32, 982-989.
73. Geusens, P.; Wouters, C.; Nijs, J.; Jiang, Y.; Dequeker, J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arth. Rheum., 1994, 37, 824-829.
74. Volker, D.; Fitzgerald, P.; Major, G.; Garg, M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J. Rheumatol., 2000, 27, 2343-2346.
75. Adam, O.; Beringer, C.; Kless, T.; Lemmen, C.; Adam, A.; Wiseman, M.; Adam, P.; Klimmek, R.; Forth, W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int., 2003, 23, 27-36.
76. Remans, P.H.; Sont, J.K.; Wagenaar, L.W.; Wouters-Wesseling, W.; Zuijderduin, W.M.; Jongma, A.; Breedveld, F.C.; van Laar, J.M. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur. J. Clin. Nutr., 2004, 58, 839-845.
77. Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J. Int. Med. Res., 2004, 32, 443-454.
78. Berbert, A.A.; Kondo, C.R.; Almendra, C.L.; Matsuo, T.; Dichi, I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition, 2005, 21, 131-136.
79. Galarraga, B.; Ho, M.; Youssef, H.M.; Hill, A.; McMahon, H.; Hall, C.; Ogston, S.; Nuki, G.; Belch, J.J. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford), 2008, 47, 665-669.
80. Calder, P.C. PUFA, inflammatory processes and rheumatoid arthritis. Proc. Nutr. Soc., 2008, 67, 409-418.
81. Volker, D.; Garg, M. Dietary n-3 fatty acid supplementation in rheumatoid arthritis - mechanisms, clinical outcomes, controversies, and future directions. J. Clin. Biochem. Nutr., 1996, 20, 83-87.
82. James, M.J.; Cleland, L.G. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin. Arthritis Rheum., 1997, 27, 85-97.
83. Geusens, P.P. N-3 fatty acids in the treatment of rheumatoid arthritis. In Medicinal Fatty Acids in Inflammation, Kremer, J.M., Ed.; Birkhauser Verlag: Amsterdam, 1998, pp. 111-123.
84. Kremer, J.M. N-3 fatty acid supplements in rheumatoid arthritis. Am. J. Clin. Nutr., 2000, 71, 349S-351S.
85. Calder, P.C. The scientific basis for fish oil supplementation in rheumatoid arthritis. In Nutritional Supplements in Health and Disease, Ransley, J.K.; Donnelly, J.K.; Read, N.W., Eds.; Springer Verlag: London, 2001, pp. 175-197.
86. Calder, P.C.; Zurier, R.B. Polyunsaturated fatty acids and rheumatoid arthritis. Curr. Opin. Clin. Nutr. Metab. Care, 2001, 4, 115-121.
87. Fortin, P.R.; Lew, R.A.; Liang, M.H.; Wright, E.A.; Beckett, L.A.; Chalmers, T.C.; Sperling, R.I. Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis. J. Clin. Epidemiol. 1995, 48, 1379-1390.
88. MacLean, C.H.; Mojica, W.A.; Morton, S.C.; Pencharz, J.; Hasenfeld Garland, R.; Tu, W.; Newberry, S.J.; Jungvig, L.K.; Grossman, J.; Khanna, P.; Rhodes, S.; Shekelle, P. Effects of omega-3 fatty acids on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evidence Report/ Technical Assessment No. 89. AHRQ Publication No. 04-E012-2, Agency for Healthcare Research and Quality, Rockville; 2004.
89. Goldberg, R.J.; Katz, J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 2007, 129, 210-223.
90. Vilaseca, J.; Salas, A.; Guarner, F.; Rodriguez, R.; Martinez, M.; Malagelada, J.-R. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut, 1990, 31, 539-544.
91. Empey, L.R.; Jewell, L.D.; Garg, M.L.; Thomson, A.B.; Clandinin, M.T.; Fedorak, R.N. Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can. J. Physiol. Pharm., 1991, 69, 480-487.
92. Shoda, R.; Matsueda, K.; Yamato, S.; Umeda, N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J. Gastroenterol., 1995, 30(Suppl 8), 98-101.
93. Yuceyar, H.; Ozutemiz, O.; Huseyinov, A.; Saruc, M.; Alkanat, M.; Bor, S.; Coker, I.; Batur, Y. Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prost. Leuk. Essent. Fatty Acids, 1999, 61, 339-345.
94. Nieto, N.; Torres, M.I.; Rios, A.; Gil, A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J. Nutr., 2002, 132, 11-19.
95. Andoh, A.; Tsujikawa, T.; Ishizuka, I.; Araki, Y.; Sasaki, M.; Koyama, S.; Fujiyama, Y. N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int. J. Mol. Med., 2003, 12, 721-725.
96. Chapkin, R.S.; Davidson, L.A.; Ly, L.; Weeks, B.R.; Lupton, J.R.; McMurray, D.N. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J. Nutr., 2007, 137, 200S-204S.
97. Lorenz, R.; Weber, P.C.; Szimnau, P.; Heldwein, W.; Strasser, T.; Loeschke, K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease - a randomized, placebo-controlled, double-blind cross-over trial. J. Intern. Med. Suppl., 1989, 731, 225-232.
98. Hillier, K.; Jewell, R.; Dorrell, L.; Smith, C.L. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut, 1991, 32, 1151-1155.
99. Hawthorne, A.B.; Daneshmend, T.K.; Hawkey, C.J.; Belluzzi, A.; Everitt, S.J.; Holmes, G.K.; Malkinson, C.; Shaheen, M.Z.; Willars, J.E. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut, 1992, 33, 922-928.
100. McCall, T.B.; O'Leary, D.; Bloomfield, J.; O'Morain, C.A. Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment. Pharmacol. Ther., 1989, 3, 415-424.
101. Shimizu, T.; Fujii, T.; Suzuki, R.; Igarashi, J.; Ohtsuka, Y.; Nagata, S.; Yamashiro, Y. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. Pediatr. Gastroenterol. Nutr., 2003, 37, 581-585.
102. Stenson, W.F.; Cort, D.; Rodgers, J.; Burakoff, R.; DeSchryver-Kecskemeti, K.; Gramlich, T,L,; Beeken, W. Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med., 1992, 116, 609-614.
103. Trebble, T.M.; Arden, N.K.; Wootton, S.A.; Calder, P.C.; Mullee, M.; Fine, D.R.; Stroud, M.A. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn's disease. Am. J. Clin. Nutr., 2004, 80, 1137-1144.
104. Salomon, P.; Kornbluth, A.A.; Janowitz, H.D. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J. Clin. Gastroenterol., 1990, 12, 157-161.
105. Aslan, A.; Triadafilopoulos, G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am. J. Gastroenterol., 1992, 87, 432-437.
106. Greenfield, S.M.; Green, A.T.; Teare, J.P.; Jenkins, A.P.; Punchard, N.A.; Ainley, C.C.; Thompson, R.P. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment. Pharmacol. Ther., 1993, 7, 159-166.
107. Belluzzi, A.; Brignola, C.; Campieri, M.; Pera, A.; Boschi, S.; Miglioli, M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N. Eng. J. Med., 1996, 334, 1557-1560.
108. Loeschke, K.; Ueberschaer, B.; Pietsch, A.; Gruber, E.; Ewe, K.; Wiebecke, B.; Heldwein, W.; Lorenz, R. n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig. Dis. Sci., 1996, 41, 2087-2094.
109. Lorenz-Meyer, H.; Bauer, P.; Nicolay, C.; Schulz, B.; Purrmann, J.; Fleig, W.E.; Scheurlen, C.; Koop, I.; Pudel, V.; Carr, L. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease: A randomized controlled multicenter trial. Scand. J. Gastroenterol., 1996, 31, 778-785.
110. Mantzaris, G.; Archavlis, E.; Zografos, C.; Petraki, K.; Spiliades, C.; Triantafyllou, G. A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis. Hellen. J. Gastroenterol., 1996, 9, 138-141.
111. Almallah, Y.Z.; Richardson, S.; O'Hanrahan, T.; Mowat, N.A.; Brunt, P.W.; Sinclair, T.S.; Ewen, S.; Heys, S.D.; Eremin, O. Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am. J. Gastroenterol., 1998, 93, 804-809.
112. Almallah, Y.Z.; Ewen, S.W.; El-Tahir, A.; Mowat, N.A.; Brunt, P.W.; Sinclair, T.S.; Heys, S.D.; Eremin, O. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFA): the mucosal effect in situ. J. Clin. Immunol., 2000, 20, 68-76.
113. Varghese, T.; Coomansingh, D. Clinical response of ulcerative colitis with dietary omega-3 fatty acids: a double-blind randomized study. Br. J. Surg., 2000, 87(Suppl. 1), 73.
114. Trebble, T.M.; Stroud, M.A.; Wootton, S.A.; Calder, P.C.; Fine, D.R.; Mullee, M.A.; Moniz, C.; Arden, N.K. High dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial. Br. J. Nutr., 2005, 94, 253-261.
115. Romano, C.; Cucchiara, S.; Barabino, A.; Annese, V.; Sferlazzas, C. SIGENP Italian Study Group of Pediatric Inflammatory Bowel Diseases. Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: adouble-blind, randomized, placebo-controlled study. World J. Gastroenterol., 2005, 11, 7118-7121.
116. Feagan, B.G.; Sandborn, W.J.; Mittmann, U.; Bar-Meir, S.; D'Haens, G.; Bradette, M.; Cohen, A.; Dallaire, C.; Ponich, T.P.; McDonald, J.W.; Hébuterne, X.; Paré, P.; Klvana, P.; Niv, Y.; Ardizzone, S.; Alexeeva, O.; Rostom, A.; Kiudelis, G.; Spleiss, J.; Gilgen, D.; Vandervoort, M.K.; Wong, C.J.; Zou, G.Y.; Donner, A.; Rutgeerts, P. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA, 2008, 299, 1690-1697.
117. Calder, P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res., 2008, 52, 885-897.
118. Rodgers, J.B. N-3 fatty acids in the treatment of ulcerative colitis. In Medicinal Fatty Acids in Inflammation. Kremer, J.M., Ed.; Birkhauser Verlag: Basel, 1998, pp. 103-109.
119. Belluzzi, A. Polyunsaturated fatty acids and inflammatory bowel disease. Am. J. Clin. Nutr., 2000, 71, 339S-342S.
120. Belluzzi, A. N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc. Nutr. Soc., 2002, 61, 391-395.
121. Teitelbaum, J.E.; Walker, W.A. Review: the role of omega 3 fatty acids in intestinal inflammation. J. Nutr. Biochem., 2001, 12, 21-32.
122. Mills, S.C.; Windsor, A.C.; Knight, S.C. The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin. Exp. Immunol., 2005, 142, 216-228.
123. Payan, D.G.; Wong, M.Y.; Chernov-Rogan, T.; Valone, F.H.; Pickett, W.C.; Blake, V.A.; Gold, W.M.; Goetzl, E.J. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J. Clin. Immunol., 1986, 6, 402-410.
124. Arm, J.P.; Horton, C.E.; Mencia-Huerta, J.M.; House, F.; Eiser, N.M.; Clark, T.J.; Spur, B.W.; Lee, T.H. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax, 1988, 43, 84-92.
125. Kirsch, C.M.; Payan, D.G.; Wong, M.Y.; Dohlman, J.G.; Blake, V.A.; Petri, M.A.; Offenberger, J.; Goetzl, E.J.; Gold, W.M. Effect of eicosapentaenoic acid in asthma. Clin. Allergy, 1988, 18, 177-187.
126. Schachter, H.; Reisman, J.; Tran, K.; Dales, B.; Kourad, K.; Barnes, D.; Sampson, M.; Morrison, A.; Gaboury, I.; Blackman, J. Health effects of omega-3 fatty acids on asthma. Evidence Report/Technical Assessment No. 91. AHRQ Publication No. 04-E013-2, Agency for Healthcare Research and Quality, Rockville; 2004.
127. Arm, J.P.; Horton, C.E.; Spur, B.W.; Mencia-Huerta, J.M.; Lee, T.H. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am. Rev. Respir. Dis., 1989, 139, 1395-1400.
128. Stenius-Aarniala, B.; Aro, A.; Hakulinen, A.; Ahola, I.; Seppala, E.; Vapaatalo, H. Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann. Allergy, 1989, 62, 534-537.
129. Dry, J.; Vincent, D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int. Arch. Allergy Appl. Immunol., 1991, 95, 156-157.
130. McDonald, C.F.; Vecchie, L.; Pierce, R.J.; Strauss, B.J.B. Effect of fish oil derived omega-3 fatty acid supplements on asthma control. Aust. NZJ Med., 1990, 20, 526.
131. Thien, F.C.; Mencia-Huerta, J.M.; Lee, T.H. Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am. Rev. Respir. Dis., 1993, 147, 1138-1143.
132. Broughton, K.S.; Johnson, C.S.; Pace, B.K.; Liebman, M.; Kleppinger, K.M. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am. J. Clin. Nutr., 1997, 65, 1011-1017.
133. Hodge, L.; Salome, C.M.; Hughes, J.M.; Liu-Brennan, D.; Rimmer, J.; Allman, M.; Pang, D.; Armour, C.; Woolcock, A.J. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur. Respir. J., 1998, 11, 361-365.
134. Nagakura, T.; Matsuda, S.; Shichijyo, K.; Sugimoto, H.; Hata, K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur. Respir. J., 2000, 16, 861-865.
135. Thien, F.C.K.; Woods, R.; De Luca, S.; Abramson, M.J. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst. Rev., 2002, 2, CD001283.
136. Grimble, R.F.; Howell, W.M.; O'Reilly, G.; Turner, S.J.; Markovic, O.; Hirrell, S.; East, J.M.; Calder, P.C. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am. J. Clin. Nutr., 2002, 76, 454-459.